MedTrace Logo

Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke

NCT01643525 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2024-07-08

Study results available
· View outcomes & findings →

Summary

That the Jan Medical Nautilus NeuroWaveTM system provides significantly higher sensitivity to hyper acute ischemic stroke than does CT.

Conditions

Interventions

DEVICE

Nautilus NeuroWaveTM System

Non-invasive device designed to detect pressure signals from the skull to aid in the diagnosis of ischemic stroke.

Sponsors & Collaborators

  • Jan Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Paul Nyquist · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01643525 on ClinicalTrials.gov